Clinical Trials
6 trialsNCT01687647 2026-05-29
AMORCE-CBP
University Hospital, Caen
Phase 3 Terminated
NCT02780128 2026-03-10
NEPENTHE
Children's Hospital of Philadelphia
Phase 1 Terminated
NCT04827563 2026-03-04
Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib
University of Chicago
Terminated
NCT02839681 2019-05-21
Anti-Mesothelin Antibody Drug Conjugate Anetumab Ravtansine for Mesothelin Expressing Lung Adenocarcinoma
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT00523471 2016-02-26
Blood Test to Measure DNA Damage in Blood
AHS Cancer Control Alberta
Terminated
NCT01608919 2015-08-10
Predictive Value of Whole Blood Coagulation Parameters for Post-discharge Venous Thromboembolism After Cancer Resection
University of Colorado, Denver
Phase NA Terminated